4 Ways Ocrevus Can Improve Your Life

Ocrevus was approved by the FDA at the end of March but the buzz hasn’t died down.Though there is some trepidation, the MS community is incredibly excited about what the new “game-changing” medication can do for patients all across the country.

Here are just a few ways that Ocrevus can improve patients’ quality of life:

It’s only administered every six months. 
While many drugs are administered daily or weekly, Ocrevus is only administered twice a year after the initial dose (which is split in half and injected two weeks apart). Though the administration needs to be overseen by a health care team (meaning you have to go somewhere for treatment), at least patients will only have to worry about scheduling the doses every six months.

It can delay the progression of the disease. 
Clearly, this is the big one. The MS community is so excited about Ocrevus because it’s the first drug approved for PPMS, and preliminary results showed that it can slow the progression of the disease.

MORE: Five things to know about the new MS drug Ocrevus

It can limit relapses. 
In addition to slowing the progression of the disease, Ocrevus has also been shown to stop relapses (in the trial, it halted the disease in nearly half of RMS patients) and improve symptoms. Many patients in the clinical trial saw reduced pain levels and improved brain function (a.k.a. less brain fog).

It can improve your body’s ability to move. 
As MS progresses, walking often becomes more difficult. One of the key markers in the Ocrevus clinical trials was the walk test. Patients taking Orevus reduced the time required to walk 25 feet by 29 percent. In addition to walking ability, researchers studied MS patients ability to move their bodies on Ocrevus, and those scores improved as well.

MORE: Ocrevus approval: a quick cheat sheet

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


  1. Anonymous says:

    Very few people can afford the medication($70,000 per dose) but manufacturer will help if you need assistance paying for it

  2. Kristin Neyhart says:

    I’ve been on several MS medications over the years tysabri betaseron tecfedera now copaxone was very active now can hardly move trying to keep a neurologist is another task

    • joann kaplan says:

      Hi Julie: I am trying to find out the exact same thing. Everything I read only references R&R or SPMS. However, my doctor suggests I take Ocrevus even though I am SPMS.

  3. Pam Tanguay says:

    This drug sounds really promising. I am on Tysabri now. My only fear is the increase for breast cancer since it runs in my family. If I decide to switch to this drug, I will mandate that I have mammograms every 6 months at least.

Leave a Comment

Your email address will not be published. Required fields are marked *